{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:40:07Z","timestamp":1781138407048,"version":"3.54.1"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine causal associations between genetically predicted TNF-\u03b1, IL-12p70 and IL-17 levels and risk of PsA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The publicly available summary-level findings from genome-wide association studies (GWAS) was used to identify loci influencing normal physiological concentrations of TNF-\u03b1, IL-12p70 and IL-17 (n\u2009=\u20098293) among healthy individuals as exposure and a GWAS for PsA from the UK Biobank (PsA = 900, control = 462\u00a0033) as the outcome. A two-sample Mendelian randomization (MR) analysis was performed using the inverse-variance weighted (IVW), weighted median and MR\u2013Egger regression methods. Sensitivity analysis and MR\u2013Egger regression analysis were performed to evaluate the heterogeneity and pleiotropic effects of each variant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Single-nucleotide polymorphisms (SNPs) at genome-wide significance from GWASs on TNF-\u03b1, IL-12p70 and IL-17 were identified as the instrumental variables. The IVW method indicated a causal association between increased IL-17 level and risk of PsA (\u03b2\u2009=\u2009\u22120.00186 per allele, s.e.\u2009=\u20090.00043, P\u2009=\u20090.002). Results were consistent in the weighted median method (\u03b2\u2009=\u2009\u22120.00145 per allele, s.e.\u2009=\u20090.00059, P\u2009=\u20090.014) although the MR\u2013Egger method suggested a non-significant association (\u03b2 =\u2009\u22120.00133 per allele, s.e.\u2009=\u20090.00087; P\u2009=\u20090.087). Single SNP MR results revealed that the C allele of rs117556572 was robustly associated with risk of PsA (\u03b2\u2009=\u20090.00210, s.e.\u2009=\u20090.00069, P\u2009=\u20090.002). However, no evidence for a causal effect was observed between TNF-\u03b1, IL-12p70, decreased IL-17 levels and risk of PsA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings provide preliminary evidence that genetic variants predisposing to higher physiological IL-17 level are associated with decreased risk of PsA.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa629","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T20:13:38Z","timestamp":1603916018000},"page":"1963-1973","source":"Crossref","is-referenced-by-count":10,"title":["The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study"],"prefix":"10.1093","volume":"60","author":[{"given":"Dongze","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"},{"name":"Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H M","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[{"name":"Bone Quality and Health Centre of the Department of Orthopedics & Traumatology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Shan","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieruo","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,14]]},"reference":[{"key":"2021040620352915900_keaa629-B1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2021040620352915900_keaa629-B2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2021040620352915900_keaa629-B3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"2021040620352915900_keaa629-B4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BOR.0000000000000136","article-title":"What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis?","volume":"27","author":"Eder","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"2021040620352915900_keaa629-B5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet"},{"key":"2021040620352915900_keaa629-B6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat Genet"},{"key":"2021040620352915900_keaa629-B7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","volume":"42","year":"2010","journal-title":"Nat Genet"},{"key":"2021040620352915900_keaa629-B8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"2021040620352915900_keaa629-B9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat Genet"},{"key":"2021040620352915900_keaa629-B10","doi-asserted-by":"crossref","first-page":"e1000041","DOI":"10.1371\/journal.pgen.1000041","article-title":"A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci","volume":"4","author":"Liu","year":"2008","journal-title":"PLoS Genet"},{"key":"2021040620352915900_keaa629-B11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2021040620352915900_keaa629-B12","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun"},{"key":"2021040620352915900_keaa629-B13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","article-title":"Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis","volume":"42","author":"Huffmeier","year":"2010","journal-title":"Nat Genet"},{"key":"2021040620352915900_keaa629-B14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/jid.2011.415","article-title":"Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL","volume":"132","author":"Ellinghaus","year":"2012","journal-title":"J Invest Dermatol"},{"key":"2021040620352915900_keaa629-B15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1136\/annrheumdis-2014-207190","article-title":"A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk","volume":"74","author":"Julia","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021040620352915900_keaa629-B16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/art.37885","article-title":"Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis","volume":"65","author":"Apel","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021040620352915900_keaa629-B17","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/annrheumdis-2014-207187","article-title":"PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus","volume":"74","author":"Bowes","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021040620352915900_keaa629-B18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/annrheumdis-2018-214158","article-title":"Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis","volume":"78","author":"Aterido","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620352915900_keaa629-B19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.12142","article-title":"Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris","volume":"168","author":"Yang","year":"2013","journal-title":"Br J Dermatol"},{"key":"2021040620352915900_keaa629-B20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat Genet"},{"key":"2021040620352915900_keaa629-B21","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1093\/hmg\/dds295","article-title":"Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes","volume":"21","author":"Julia","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2021040620352915900_keaa629-B22","first-page":"84","article-title":"Identification of a single nucleotide polymorphism in NFKBIA with different effects on psoriatic arthritis and cutaneous psoriasis in China","volume":"99","author":"Zhao","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"2021040620352915900_keaa629-B23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"2021040620352915900_keaa629-B24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.55563\/clinexprheumatol\/8thj0l","article-title":"Evidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence","volume":"38","author":"Solmaz","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620352915900_keaa629-B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations","volume":"33","author":"Smith","year":"2004","journal-title":"Int J Epidemiol"},{"key":"2021040620352915900_keaa629-B26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"2021040620352915900_keaa629-B27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"2021040620352915900_keaa629-B28","doi-asserted-by":"crossref","first-page":"e1001976","DOI":"10.1371\/journal.pmed.1001976","article-title":"Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study","volume":"13","author":"Prins","year":"2016","journal-title":"PLoS Med"},{"key":"2021040620352915900_keaa629-B29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"key":"2021040620352915900_keaa629-B30","first-page":"078972","author":"Hemani","year":"2016","journal-title":"bioRxiv"},{"key":"2021040620352915900_keaa629-B31","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2021040620352915900_keaa629-B32","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2021040620352915900_keaa629-B33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators","volume":"178","author":"Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"2021040620352915900_keaa629-B34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2021040620352915900_keaa629-B35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2021040620352915900_keaa629-B36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2021040620352915900_keaa629-B37","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"2021040620352915900_keaa629-B38","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2021040620352915900_keaa629-B39","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat Immunol"},{"key":"2021040620352915900_keaa629-B40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the yin and the yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol"},{"key":"2021040620352915900_keaa629-B41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"2021040620352915900_keaa629-B42","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2005-09-010116","article-title":"An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals","volume":"109","author":"Yu","year":"2007","journal-title":"Blood"},{"key":"2021040620352915900_keaa629-B43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ni.2260","article-title":"The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss","volume":"13","author":"Eskan","year":"2012","journal-title":"Nat Immunol"},{"key":"2021040620352915900_keaa629-B44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2016.12.010","article-title":"On-going mechanical damage from mastication drives homeostatic Th17 cell responses at the oral barrier","volume":"46","author":"Dutzan","year":"2017","journal-title":"Immunity"},{"key":"2021040620352915900_keaa629-B45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1189\/jlb.0211099","article-title":"Mechanisms controlling Th17 cytokine expression and host defense","volume":"90","author":"McAleer","year":"2011","journal-title":"J Leukoc Biol"},{"key":"2021040620352915900_keaa629-B46","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3389\/fimmu.2018.01550","article-title":"The initiation, but not the persistence, of experimental spondyloarthritis is dependent on interleukin-23 signaling","volume":"9","author":"van Tok","year":"2018","journal-title":"Front Immunol"},{"key":"2021040620352915900_keaa629-B47","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4CD8 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"2021040620352915900_keaa629-B48","doi-asserted-by":"crossref","first-page":"102429","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2021040620352915900_keaa629-B49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2021040620352915900_keaa629-B50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.40770","article-title":"Interleukin-17A inhibition diminishes inflammation and new bone formation in experimental spondyloarthritis","volume":"71","author":"van Tok","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021040620352915900_keaa629-B51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13075-019-1957-0","article-title":"Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study","volume":"21","author":"Kampylafka","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2021040620352915900_keaa629-B52","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis","volume":"67","author":"Belasco","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021040620352915900_keaa629-B53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-018-1653-5","article-title":"Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study","volume":"20","author":"Kampylafka","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021040620352915900_keaa629-B54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-015-0529-9","article-title":"Contribution of the IL-17 pathway to psoriasis and psoriatic arthritis","volume":"17","author":"Durham","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"2021040620352915900_keaa629-B55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13075-017-1249-5","article-title":"Mechanistic rationales for targeting interleukin-17A in spondyloarthritis","volume":"19","author":"Raychaudhuri","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2021040620352915900_keaa629-B56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9440(10)62961-6","article-title":"Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1","volume":"167","author":"Koenders","year":"2005","journal-title":"Am J Pathol"},{"key":"2021040620352915900_keaa629-B57","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-\u03baB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2021040620352915900_keaa629-B58","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"2021040620352915900_keaa629-B59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"2021040620352915900_keaa629-B60","doi-asserted-by":"crossref","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Uluckan","year":"2016","journal-title":"Sci Transl Med"},{"key":"2021040620352915900_keaa629-B61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","article-title":"IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis","volume":"18","author":"Shaw","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021040620352915900_keaa629-B62","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/key312","article-title":"Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis","volume":"58","author":"Khatri","year":"2019","journal-title":"Rheumatology (Oxford"},{"key":"2021040620352915900_keaa629-B63","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/art.40579","article-title":"Phase II study of ABT-122, a tumor necrosis factor- and interleukin-17A-targeted dual variable domain immunoglobulin, in patients with psoriatic arthritis with an inadequate response to methotrexate","volume":"70","author":"Mease","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021040620352915900_keaa629-B64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(19)33161-7","article-title":"Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial","volume":"395","author":"Ritchlin","year":"2020","journal-title":"Lancet"},{"key":"2021040620352915900_keaa629-B65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021040620352915900_keaa629-B66","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/EDE.0000000000000161","article-title":"Instrumental variable analysis with a nonlinear exposure-outcome relationship","volume":"25","author":"Burgess","year":"2014","journal-title":"Epidemiology"},{"key":"2021040620352915900_keaa629-B67","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/ije\/dyu187","article-title":"Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits","volume":"43","author":"Silverwood","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2021040620352915900_keaa629-B68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ejhg.2016.205","article-title":"Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom","volume":"25","author":"Chheda","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2021040620352915900_keaa629-B69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"2021040620352915900_keaa629-B70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ajhg.2008.11.005","article-title":"The genome-wide patterns of variation expose significant substructure in a founder population","volume":"83","author":"Jakkula","year":"2008","journal-title":"Am J Hum Genet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1963\/36912642\/keaa629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1963\/36912642\/keaa629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T08:15:55Z","timestamp":1669364155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1963\/5981747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,14]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,11,14]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa629","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,11,14]]}}}